Keith Tapper
Stock Analyst at BMO Capital
(0)
# 4452
Out of 5,333 analysts
6
Total ratings
33.33%
Success rate
-14.14%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NGNE Neurogene | Maintains: Outperform | 45 16 | 14.73 | 8.62% | 4 | Apr 14, 2025 | |
TSHA Taysha Gene Therapies | Initiates Coverage On: Outperform | 5 | 2.12 | 135.85% | 1 | Jun 27, 2024 | |
ACAD ACADIA Pharmaceuticals | Initiates Coverage On: Outperform | 31 | 17.46 | 77.55% | 1 | Jun 27, 2024 |